University of Copenhagen Spin-out Raises $154m Targeting Novel Immune-Modulating Anti-Cancer Therapies
IO Biotech, a Danish clinical-stage biotech venture developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology raised EUR […]